Abode Drugs Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2008.
2008 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Abode Drugs Private Limited

Abode Drugs Private Limited, a active private limited company, was established on 25 April 2008 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the professional, scientific and technical sector, it holds CIN: U24232TG2008PTC058838. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Prakash Rao Nayaneni (Director), Prakash Sharat Kumar Naineni (Director). It holds ₹2.98 M open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at H.No.5-4-22/1, Sri Rama Nilayam Kukatpally, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2008PTC058838

  • Registration Number

    058838

  • Incorporation Date

    25 April 2008

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 17 Year, 10 Months
  • Last Filing with ROC 31 Mar 2019
  • Open Charges ₹ 2.98 M
  • Revenue Growth **** -33.28%
  • Profit Growth **** -75.29%
  • Ebitda **** -165.19%
  • Net Worth 3.86%
  • Total Assets **** 1.84%
Company report

Abode Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Abode Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Abode Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Prakash Rao Nayaneni Director 25 Apr 2008 Current
Prakash Sharat Kumar Naineni Director 25 Apr 2008 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Abode Drugs.

Abode Drugs Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 33.28% decrease. The company also saw a substantial fall in profitability, with a 75.29% decrease in profit. The company's net worth moved up by a moderate rise of 3.86%.

Abode Drugs revenue growth over time
Abode Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -33.28%
*******
*******
*******
*******
Revenue from Operations
*******
 -33.28%
*******
*******
*******
*******
Total Assets
*******
 1.84%
*******
*******
*******
*******
Profit or Loss
*******
 -75.29%
*******
*******
*******
*******
Net Worth
*******
 3.86%
*******
*******
*******
*******
EBITDA
*******
 -165.19%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Abode Drugs?

In 2016, Abode Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,978,599.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
16 Feb 2021 Hdfc Bank Limited ₹1.54 M Open
25 Jan 2021 Hdfc Bank Limited ₹1.44 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Abode Drugs?

Abode Drugs has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Abode Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abode Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Abode Drugs
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.54 M with Charge ID 100443716 was registered on 16 Feb 2021. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 1.44 M with Charge ID 100443091 was registered on 25 Jan 2021. was completed.

  • Annual General Meeting

    Abode Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Abode Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    The activity Prakash Rao Nayaneni was appointed as a Director was appointed as a Director on 25 Apr 2008 & has been associated with this company since 17 years 10 months . was completed.

  • Director Appointment

    Progress on Prakash Sharat Kumar Naineni was appointed as a Director was appointed as a Director on 25 Apr 2008 & has been associated with this company since 17 years 10 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Abode Drugs Private Limited?

The CIN of Abode Drugs Private Limited is U24232TG2008PTC058838.

Where is Abode Drugs Private Limited headquartered?

Abode Drugs Private Limited is headquartered at H.No.5-4-22/1, Sri Rama Nilayam Kukatpally, Hyderabad, Telangana, 500072.

When was Abode Drugs Private Limited incorporated?

Abode Drugs Private Limited was incorporated on 25 April 2008.

Who are the current directors of Abode Drugs Private Limited?

The current directors of Abode Drugs Private Limited are

What is the primary industry of Abode Drugs Private Limited?

The primary industry of Abode Drugs Private Limited is Professional, Scientific And Technical.

Is Abode Drugs Private Limited a listed company?

Abode Drugs Private Limited is unlisted.

What is the capital structure of Abode Drugs Private Limited?

The authorized capital of Abode Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Abode Drugs Private Limited?

The compliance status of Abode Drugs Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available